Drug Discovery 2015

Posters

Marie Labus
Newcastle University
1Development of disease modifying drugs for osteoarthritis
Chris Morris
STFC
2Visualizing Disease-Gene Relationships
Jayme Dahlin
Mayo Clinic
United States
3Promiscuous in vitro bioassay activity of the natural product garcinol, a reported inhibitor of histone acetyltransferases
Basma Al-sudani
salford university
4Selection of Circular ssDNA Aptamers against Sirtuin1 protein by SELEX Methodology
Dermott O'Callaghan
The Research Network
5The Research Network - Building New Therapeutic Ventures
Jacqueline Naylor
MedImmune
United States
8Use of Incretin Receptor Knock-Out β–cell Lines for Dual Agonism Drug Discovery
Gemma Kinsella
Dublin Institute of Technology
Ireland
9GPR21, A novel target for Type 2 Diabetes
Pilaslak Akrachalanont
University of strathclyde
10Anthelminthic Drug Target Identification and Validation
Radu Tamaian
ICSI Rm.Valcea
Romania
11In silico modelling of the biodistribution of therapeutic immunoconjugates with thiazolic payload
Helen Boyd
AstraZeneca
Sweden
12Building an understanding of type IV bromodomains.
Helen Boyd
AstraZeneca
Sweden
13Hunting for hits for E3 ligases
Agathe Devaux
CELENYS
France
14HYALURONIC ACID SCAFFOLD FOR 3D CELL CULTURE
Kate Enright
Fisher BioServices
15Understanding the effect of short term temperature excursions on cell therapies
Emma Shanks
CRUK Beatson Institute
16Genes within the 3q26-29 amplicon present novel therapeutic candidates for oral cancer
Emma Shanks
CRUK Beatson Institute
17Academic Drug Discovery within the UK - a reassessment
shazia khan
student
Pakistan
18DNA analyser
Steve Brough
Key Organics
19Building a Diverse and Experimentally-Curated Fragment Library
Steve Brough
Key Organics
20Rapid Virtual Library Screening and Synthesis for Selective Hit Identification
Elsa Breau
AMSBIO
21High throughput in vitro microtumor model for drug screening
salha tawati
strathclyde university
22 DEVELOPMENT OF DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES
Robert-Jan Lamers
Abundnz B.V.
Netherlands
23A novel ultrasensitive assay for bioanalytical studies with innovative medicines
Banusha Rajeenthira
MRC Technology
26A protein engineering approach to explore the binding mode for inhibitors of the de novo purine biosynthetic enzyme PAICS
Afrah Sattikar
MRC Technology
27Validation and optimisation of novel antagonists of MIF
Daniel Tams
Roslin Cells
28Banking and Characterisation of Human Induced Pluripotent Stem Cells for Drug Discovery Applications
Alan Morgan
University of Liverpool
Afghanistan
29Using nematode worm models of human neurological diseases to identify novel therapeutic drugs and mechanisms of action.
Catherine Gouveia
Cytome Technologies Ltd
30Next Generation Protein Profiling Using inCYT
François Degorce
Cisbio Bioassays
France
31How do HTRF® epigenetic binding domain assays perform compared to other technologies ?
François Degorce
Cisbio Bioassays
France
32New cell-based HTRF® assays for the exploration of Wnt signaling pathway
François Degorce
Cisbio Bioassays
France
33Universal HTRF® phospho-protein platform : from 2D, 3D, primary cells to patient derived tumor cells
Alasdair Robertson
SAL Scientific Ltd
34Optimised Conditions for Cell Growth in Defined Media
Kelly Davidge
Kirkstall
35Advances in in vitro testing: the route to replace animal testing
Antonella Ragnini-Wilson
University of Rome Tor Vergata
Italy
36A novel cell-based assay to identify compounds acting in central nervous system re-myelination
Daniela Natale
IRBM Science Park S.p.A.
Italy
37Identification and validation of a new class of HDAC inhibitors able to induce HbF in thalassemic erythroid precursors.
Thalia Carreno
University of Sussex
Mexico
38A structure-based approach to identifying novel modulators of the Nrf2 transcription pathway
Tyrrell Norris
AstraZeneca
Sweden
40Identification of small molecule inhibitors of FoxO1 using large scale transiently transfected assay-ready cells in HTS
Elsa Breau
AMSBIO
41Monitoring the interplay between oxygen availability and metabolism in tumor biology using high throughput measurements of 3D cell models
Alan Sandercock
MedImmune
42High content screening of cell-surface-selected antibodies in a complex 3D tumour cell model
Christoph Sachse
NMI TT Pharmaservices
Germany
43Comprehensive profiling of signal transduction pathways in tumour tissues, using DigiWest, a novel multiplex protein profiling method
Christoph Sachse
NMI TT Pharmaservices
Germany
44Characterisation of β-catenin complexes by Chromobody-based intracellular co-immunoprecipatation and DigiWest protein profiling
Valerie Legris
Electrospinning Company
45Liver cancer cells grown in 3D in the Mimetix scaffold regain a primary-like phenotype
David Calvo
GSK
Spain
46High Throughput Measurement of Mitochondrial Membrane Potential
Anders Hanning
Episentec AB
Sweden
47Label-Enhanced SPR Improves the Detectability of Label-Free Surface Plasmon Resonance Analysis 100x
Anne Burke
EuroScitech
49Difficult to Express Proteins made easy with the Drosophila S2 based ExpreS2 system’
Joanne Walter
EuroScitech
50LabMinds Revo – an automated solution preparation system that releases scientific minds from the burden of procedural lab tasks.
Cassandra Rigby
MRC Technology
52Identification of novel, potent inhibitors of PAICS within the de novo purine synthetic pathway to target the treatment of metastatic breast cancer
Ahmad Kamal
MRC Technology
54Utilisation of the InCELL Hunter™ Target Engagement Cell-Based Assay for Profiling of ULK1 Inhibitors.
Rachel McMenamin
Mission Therapeutics
55Evaluating fluorescence lifetime technology for identification and characterisation of DUB inhibitors
Richard Griesbach
NMI
Germany
56Premium Screening Tools and Target Validation Services
Alan Fisher
PerkinElmer
57Image Based Quality Control of Cell-Based Assays Utilizing the
Alan Fisher
PerkinElmer
58Simultaneous detection of IL-6 and IL-8 secretion by cell lines using AlphaLISA and AlphaPlex 545 reagents
Eva Hansson
AstraZeneca R&D Mölndal
59Mineralocorticoid Receptor Reporter Gene Assay – optimisation for medium to high throughput screening.
Daniel Wilcock
AstraZeneca
60Taking RAS Screening to the Next Dimension
Andrea Traube
Fraunhofer IPA
Germany
61High-throughput manufacturing of human epidermal models
Laurent Brault
Exquiron Biotech AG
Switzerland
62Direct delivery of functional proteins or peptides into eukaryotic cells by a novel bacteria-based technology
Giorgia Salvagiotto
Cellular Dynamics International, A FujiFilm Company
United States
63Novel iPSC-derived cellular systems for in vitro disease modeling.
Gary Allenby
Aurelia Bioscience
64Phenotypic screening of iPS-derived cardiomyocyte toxicity ina novel 3D cell culture system
Fiona Jeganathan
Institute of Cancer Research
65Correlating thermal stability & ligand lipophilicity with KDM4A protein-ligand crystallography success.
Gareth Davies
AstraZeneca
66Screening by SPR Workflow and Software for Efficient Data Processing
Violeta Niculescu
ICIT Ramnicu Valcea
Romania
68New metallic complexes as a potential drugs for urease activity inhibition
Rebecca Dixon-Steele
AstraZeneca
69A 1536 Well Epic® Assay Development Process
Rhiannon McNeill
University of York
72Metal-binding Proteins as Novel Urothelial Biomarkers of Cadmium Exposure
Spencer Campbell
Bicycle Therapeutics
73Bicyclic peptide Drug Conjugates (BDCs) targeting MT1-MMP – a new type of anticancer agent
David Allcock
Sygnature Discovery
75Design, Synthesis and Optimisation of a Novel, Proprietary Fragment Library Using Biophysical Techniques
Russell Green
Beckman Coulter UK Ltd
76Automated 3D Cell Culture and Screening by Imaging and Flow Cytometry
Russell Green
Beckman Coulter UK Ltd
77Automated NGS Sample Prep with Integrated Data Management and Reporting Tools
Jana Kaiser
MISSION Therapeutics
78Inhibitors of USP30 for the treatment of Parkinson’s disease and other mitochondrial dysfunctions
Ana Pires
Mission Therapeutics
79Targeting USP11 for the treatment of platinum-resistant ovarian cancer
Lisa Igelmann
MISSION Therapeutics
80Development of a drug discovery platform targeting SUMO specific proteases
Jan Carsten Pieck
MERCK KGaA
Germany
81cHTS process @ MERCK KGaA
Jan Carsten Pieck
MERCK KGaA
Germany
82Enabling HCS in 1536 well format
Berwyn Lloyd
Beckman Coulter UK Ltd
88Automation of Micro RNA and Total RNA Purification from tissues using the Agencourt RNAdvance Tissue Kits and Biomek NXP Span 8 Laboratory Automation Workstation
Berwyn Lloyd
Beckman Coulter UK Ltd
89Automate Like a Pro: Fully Integrated System for ELISA and Cell Viability Absorbance Assays
Vasco Meneghini
Institute Imagine
Italy
90Intracerebral lentiviral gene therapy enables stable and widespread biodistribution of therapeutic enzymes in the brain of non-human primates
Jacqueline Rippington
Gilson Scientific ltd
91A Flexible Workflow for Automated Kinase Selectivity Profiling
Jean-Marc D'Angelo
Hamamatsu Photonics France
92Optogenetics: A Bright Future for Voltage Gated Ion Channels
Jean-Marc D'Angelo
Hamamatsu Photonics France
93BRET2 assay using the FDSS/μCELL: monitoring cell surface-receptor internalization and intracellular trafficking
Jean-Marc D'Angelo
Hamamatsu Photonics France
94Electric Field Stimulation (EFS) of human iPSC-derived neuron using Hamamatsu FDSS/μCELL
Alex Macpherson
UCB
95A Comparison of High Throughput Screening Techniques for Interrogating Membrane Bound, PPI Targets
Stephen Hobson
Newcastle University
96Radiosynthesis and Pre-clinical Imaging of [18F]Fluoroethyl choline
SHAH KHAN
OMAN MEDICAL COLLEGE
Oman
97Phytochemical screening, total phenolic and flavonoid contents, evaluation of antioxidant potential and Lipoxygenase (5-LO) inhibitory activity of aerial parts of Haplophyllum tuberculatum (Forssk) A. Juss: An Omani traditional medicine
Roland Leathers
Thermo Fisher Scientific
Switzerland
98ExpiCHO™: Surpassing the Performance of 293 in a Transient CHO Expression System
Mark Soave
University of Nottingham
99Use of an NLuc-BRET System to Investigate Ligand-Binding to the Human β1-adrenoceptor
Hernani Silvestre
Evotec
100Industrial Use of Medium-Throughput Fragment Screening by Crystal Soaking
Hernani Silvestre
Evotec
101Industrial Use of Medium-Throughput Fragment Screening by Crystal Soaking
Faiza Durrani
School of Biological Sciences,P.U.pakistan.
102Cost effective production of biologically active recombinant ovine growth hormone via SRP secretory system
Amy Heptinstall
Newcastle University
103Development of ERK5 Inhibitors for Anti-Cancer Therapy
Sylvain Blanc
Charnwood Molecular
104Direct Targets Identification of a Bioactive Compound Using Chemical Biology
Simon Lydford
Molecular Devices (UK) Ltd
105Development of a cell-based potassium-chloride transporter assay using a new FLIPR Potassium Assay Kit
Simon Lydford
Molecular Devices (UK) Ltd
106High throughput assays for characterizing the viability and morphology of 3D cancer speroid cultures
Andrea Traube
Fraunhofer IPA
Germany
107Immediate drop on demand technology � a new platform for cell applications in low-volume range
Tristan Thwaites
Axol Bioscience Ltd.
108Characterisation of iPSC-derived Neural Stem Cells and Cerebral Cortical Neurons
Nathalie MAUBON
HCS Pharma
France
109Development of neuroprotection model for Parkinson disease using High Content Screening
Nathalie MAUBON
HCS Pharma
France
110Hepatotoxicity assays by High Content Analysis
Peter Banks
BioTek Instruments
United States
111Validation of a Novel Tumoroid-Based Cell Culture Model to Perform 3D in vitro Cell Signaling Analyses
Peter Banks
BioTek Instruments
United States
112Cellular Analysis of 3D Spheroid-Based Tumor Invasion Assays
Simon Lydford
Molecular Devices (UK) Ltd
113Development of a platelet calcium flux assay using Fura-2, AM on the FlexStation 3 Multi-Mode Microplate Reader
Priyanka Narasimhan
Domainex
114A novel approach to identifying lysine methyltransferase inhibitors
Scott Cribbes
Nexcelom Bioscience Ltd
115A high-throughput direct cell counting imaging cytometry method for natural killer cell-mediated cytotoxicity detection
Claire Tebbutt
Domainex
118An Important role for TBK1/IKKε in IP10 signalling: A potential intervention in COPD
James Wilkinson
NanoTemper Technologies
Germany
119MicroScale Thermophoresis - Case Study on Automated Fragment Screening
Nicola Bevan
Essen Bioscience
120IncuCyte(TM) Chemotaxis System: a new and enabling solution for directional migration assays
Gillian Lovell
Essen BioScience
121Real time image-based quantification of phagocytosis in living cells using IncuCyte ZOOM®
Adam Hyman
University of Leeds
122Are you measuring your protein correctly? Comparison between microvolume spectrometers
Ian Willox
DiscoveRx
123Analysis of α-PD-1, α-PD-L1 and α-CTLA-4 Immune Checkpoint Antibodies in Human Primary Cell BioMAP® Oncology Systems
Nadine Wilhelm
Fraunhofer IBMT
124A HUMAN SERUM ALBUMIN-BASED GENE DELIVERY SYSTEM FOR THE SAFE VIRUS-FREE APPLICATION IN GENE AND CELL THERAPY
Scott Cribbes
Nexcelom Bioscience Ltd
125A rapid 3D tumor spheroid image cytometric analysis method for drug discovery.
Isabel Patocchi
Tecan Schweiz AG
Switzerland
126Cytochrome P450 compound profiling
Andrew Green
Discoverx
127Measuring Receptor Dimerization To Create Functional Cell-Based Assays for ~85% of the Interleukin Receptor Family
Kate Feeney
Discoverx
128Rational design of dual kinase-bromodomain inhibitors for therapeutic polypharmacology
Katherine Roper
Manchester Institute of Biotechnology
129Eve: Integration of machine learning with compound testing in a robot scientist
Masakazu Kobayashi
ZoBio BV
Netherlands
130From Genes to protein-ligand structures; a work-flow tuned for structural characterization by solution NMR
James Wilkinson
NanoTemper Technologies
Germany
131NanoTemper Prometheus NT.48 - High Precision Protein Fodling Analysis in Drug Discovery and Formulation Development by nanoDSF
Rachel Doidge
Aurelia Bioscience Ltd
132Implementation of the Tecan D300 digital dispenser improves accuracy and reproducibility of concentration response curves
Michelle Potter
Peakdale Molecular
133CYP Inhibition: To Pool or Not to Pool
Faiza Durrani
School of Biological Sciences,P.U.pakistan.
134cost effective production of biologically active recombinant ovine growth hormone via SRP secretory system
Faiza Durrani
School of Biological Sciences,P.U.pakistan.
135Molecular characterization of ovine growth hormone and growth hormone binding protein of Bubalus bubalus revealed the presence of novel amino acid.
Laurent Brault
Exquiron Biotech AG
Switzerland
136Customised solutions for successful hit discovery
Ian Gowers
Charles River
137Development of a p75NTR Homodimer NanoBRET Assay and Identification of Neurotrophins Capable of Modifying the NanoBRET signal
Agnes Martin
Cancer Research Technology
138Biophysical techniques for hit validation during small molecule drug discovery
Cristina Alli
Cancer Research Technology
139Strategies for targets sensitive to Redox Cycling Compounds
Cristina Alli
Cancer Research Technology
140Screening for small molecule inhibitors of a transcription factor target implicated in cancer
Rupert Satchell
Sygnature Discovery
141A combinatorial biophysical approach; FTSA and SPR for identifying small molecule ligands and PAINs
Dan Gare
Avacta Life Sciences
142Allosteric inhibition of FcgRIIIa-IgG interactions using Affimers
Dan Gare
Avacta Life Sciences
143Fibrinogen targeted Affimers can successfully modulate fibrin clot lysis in the presence of plasminogen inhibitor
Emily Rampling
Cambridge Bioscience
144Using Impedance-Based Approaches for Measuring Cell-Mediated Cytotoxicity and Antibody-Dependant Cell-Mediated Cytotoxicity (ADCC)
Emily Rampling
Cambridge Bioscience
145PamGene’s Kinase activity profiling of tumor tissues of different origin
Elena Tavkin
B CUBE, Technische Universität Dresden
Germany
146High-throughput microtubule gliding assay for drug screening
Richard Kasprowicz
Phase Focus Ltd
147Label-free measurement of cell death using ptychographic imaging
Linda Orren
Labcyte
United States
148Evaluation of combination treatment efficacy utilizing the Labcyte Echo® liquid handler and Echo® Combination Screen Software with reduced cost, increased throughput and flexibility in a PC3 viability assay
Linda Orren
Labcyte
United States
150Identification of HDAC1 inhibitors with an automated Fluorogenic assay using the Labcyte Access Workstation with an integrated Labcyte Echo® liquid handler and Echo® Qualified Reservoir.
Richard Somberg
Promega
United States
151Monitoring Intracellular Protein Interactions Using NanoLuc® Binary Technology (NanoBiT)
Grainne Gernon
Cancer Research Technology
152Complementary approaches to study histone lysine demethylases (KDM)
Scott Cribbes
Nexcelom Bioscience Ltd
153Consistently and accurately measure CAR T Cell concentration and viability using Cellometer image cytometry for adoptive cell transfer therepy
Craig Malcolm
Promega UK Ltd
154Investigating the cellular interactions of BIRB796 analogs using a novel Chloroalkane capture tag
Christian Schueller
PerkinElmer
Germany
155Phenotypic discovery and characterization of neuroprotective compounds relevant to ALS
Miles Rackliff
IntelliCyt Corporation
156Profiling of a compound library biased toward Immunomodulating agents: HTS of Immunophenotype, Viability, Proliferation and Cytokine secretion on a single platform
Miles Rackliff
IntelliCyt Corporation
157HIGH THROUGHPUT FLOW SCREENING ASSAYS TO PROFILE CELL-MEDIATED KILLING
Miles Rackliff
IntelliCyt Corporation
158Utilising High Throughput Flow to Screen for Differential Sensitivity of Primary Cells to Immunosuppressive Compounds
Miles Rackliff
IntelliCyt Corporation
159Better Antibody Screening Using IntelliCyt’s iQue Screener AND Comparison of FMAT and Using the iQue Screener for Cell-Based Antibody Library Screening
Count: 139



Sponsor